Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de David T. Scadden
Leeftijd : 67
Vermogen : 1 720 465 USD
Belangrijkste bedrijven : Editas Medicine, Inc. - Agios Pharmaceuticals, Inc. - Magenta Therapeutics, Inc.
Overzicht 
Founder of 7 different companies, notably: Fate Therapeutics, Inc., Magenta Therapeutics, Inc. and Massachusetts General Hospital Cancer Center, David T. Scadden is an entrepreneur is Chairman-Emeritus & Professor at Harvard University, Director-Regenerative Medicine Center at The General Hospital Corp. (he founded the company), Associate Member at Massachusetts Institute of Technology, Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Associate Member at The Broad Institute, Inc., Chairman-Emeritus & Professor at Harvard Medical School, Fellow at American College of Physicians and Member of National Academy of Medicine of United States and on the board of 7 other companies.

In the past Dr. Scadden was Director-Hematologic Malignancies Center at Massachusetts General Hospital Cancer Center (he founded the company in 2003), Member-External Experts Board at National Heart, Lung & Blood Institute and Member-Scientific Counselors Board at National Cancer Institute.

He received an undergraduate degree from Bucknell University, a graduate degree from Case Western Reserve University and a doctorate from the University of Lund.


Posities en verantwoordelijkheden van David T. Scadden 
NaamTitel Van
Editas Medicine, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2019
Agios Pharmaceuticals, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2017
Magenta Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2016
Harvard University Chairman-Emeritus & Professor 2006
Harvard Medical School Chairman-Emeritus & Professor -
Harvard Stem Cell Institute Director 2004
Red Oak Medicines, Inc. Director -
Clear Creek Bio, Inc. Director -
Lifevault Bio Director -
The General Hospital Corp. Director-Regenerative Medicine Center -
Massachusetts Institute of Technology Associate Member -
American Academy of Arts & Sciences Member -
Institute of Medicine Member -
The Broad Institute, Inc. Associate Member -
American College of Physicians Fellow -
National Academy of Medicine of United States Member -


Belangnemingen van David T. Scadden 
NaamAandelen%Totale waarde
Magenta Therapeutics, Inc. (MGTA)
(Biotechnologie & Medisch Onderzoek)
228 1750,39%1 460 320 USD
Agios Pharmaceuticals, Inc. (AGIO)
(Biotechnologie & Medisch Onderzoek)
5 5350,0094%260 145 USD
Editas Medicine, Inc. (EDIT)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


David T. ScaddenPersoonlijk netwerk 
Meest gelezen nieuws 
24/11ELON MUSK : Musk verkoopt Tesla-aandelen ter waarde van $1,05 mrd, koopt 2,15 mln aandelen
MR
06/12MUKESH AMBANI : Indiase verkopers dreigen met leveringsonderbrekingen uit protest tegen Reliance
MR
30/11JACK DORSEY : Jack Dorsey jaagt crypto, fintech droom post Twitter
MR
24/11JAMIE DIMON : Jamie Dimon grapt dat JPMorgan langer meegaat dan de communistische partij van China
MR
01/12JACK DORSEY : Dorsey-leiding Square verandert in Block met knipoog naar blockchain
MR
24/11ERIK NORDSTROM : Nordstrom-winst blijft achter bij ramingen door problemen met bevoorrading, aandelen kelderen
MR
03/12TILMAN FERTITTA : FAST Acquisition weigert fusie SPAC met Fertitta Entertainment te beëindigen
MR
29/11ANIL AMBANI : Indiase centrale bank start faillissementsprocedure tegen Reliance Capital; co moet voldoen
MR
23/11STUART ROSE : Morrisons aandeelhouders steunen CD&R's $10 mrd overname
MR
03/12ELON MUSK : Elon Musk verkoopt nog meer aandelen Tesla
AM
Meer nieuws


© 2021 People and Ownership :   
David T. Scadden Verbindingen